Free rapid scientific advice for COVID-19 treatments or vaccines

EMA has put in place a rapid scientific advice procedure for potential COVID-19 treatments and vaccines, which is free of charge.

The rapid procedure reduces review time to a maximum of 20 days (from 40-70 days), with no pre-specified submission deadlines.

In addition, flexibility can be agreed on a case-by-case basis on the type and extent of the briefing dossier.

For more information, see:

EMA and the COVID-19 EMA pandemic Task Force can provide early guidance to developers whose development plan is not yet suitable for formal rapid scientific advice.

Contact us if you need assistance in preparing such a submission. We will make sure that the documents are diligently prepared so that you can get the most out of such a scientific advice procedure.